カテゴリー： Market Monitor Global, 世界, 医療/バイオ

血漿分画技術の世界市場見通し2023年-2029年

◆英語タイトル：Blood Plasma Fractionation Technology Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23FB2163）◆商品コード：MMG23FB2163
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年2月
◆ページ数：102
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の血漿分画技術市場規模と予測を収録しています。・世界の血漿分画技術市場：売上、2018年-2023年、2024年-2029年
・世界の血漿分画技術市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の血漿分画技術市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「アルブミン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

血漿分画技術のグローバル主要企業は、Takeda、CSL、Grifols、Octapharma、Kedrion、LFB Group、Biotest、BPL、RAAS、CBPO、Hualan Bio、Tiantan Bio、Shuanglin Bio、Boya Bio、Yuanda Shuyang、Weiguang Bio、Nanyue Bio、KM Biologicsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、血漿分画技術のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の血漿分画技術市場：タイプ別、2018年-2023年、2024年-2029年
世界の血漿分画技術市場：タイプ別市場シェア、2022年
・アルブミン、免疫グロブリン、凝固因子、その他

世界の血漿分画技術市場：用途別、2018年-2023年、2024年-2029年
世界の血漿分画技術市場：用途別市場シェア、2022年
・病院、薬局、その他

世界の血漿分画技術市場：地域・国別、2018年-2023年、2024年-2029年
世界の血漿分画技術市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における血漿分画技術のグローバル売上、2018年-2023年
・主要企業における血漿分画技術のグローバル売上シェア、2022年
・主要企業における血漿分画技術のグローバル販売量、2018年-2023年
・主要企業における血漿分画技術のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Takeda、CSL、Grifols、Octapharma、Kedrion、LFB Group、Biotest、BPL、RAAS、CBPO、Hualan Bio、Tiantan Bio、Shuanglin Bio、Boya Bio、Yuanda Shuyang、Weiguang Bio、Nanyue Bio、KM Biologics

*************************************************************

・調査・分析レポートの概要
血漿分画技術市場の定義
市場セグメント
世界の血漿分画技術市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の血漿分画技術市場規模
世界の血漿分画技術市場規模：2022年 VS 2029年
世界の血漿分画技術市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの血漿分画技術の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の血漿分画技術製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：アルブミン、免疫グロブリン、凝固因子、その他
血漿分画技術のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、薬局、その他
血漿分画技術の用途別グローバル売上・予測

・地域別市場分析
地域別血漿分画技術市場規模 2022年と2029年
地域別血漿分画技術売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Takeda、CSL、Grifols、Octapharma、Kedrion、LFB Group、Biotest、BPL、RAAS、CBPO、Hualan Bio、Tiantan Bio、Shuanglin Bio、Boya Bio、Yuanda Shuyang、Weiguang Bio、Nanyue Bio、KM Biologics
...

This report aims to provide a comprehensive presentation of the global market for Blood Plasma Fractionation Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Plasma Fractionation Technology. This report contains market size and forecasts of Blood Plasma Fractionation Technology in global, including the following market information:
Global Blood Plasma Fractionation Technology Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Blood Plasma Fractionation Technology market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Albumin Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Blood Plasma Fractionation Technology include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Blood Plasma Fractionation Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
[Total Market by Segment]
Global Blood Plasma Fractionation Technology Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Blood Plasma Fractionation Technology Market Segment Percentages, by Type, 2022 (%)
Albumin
Immune Globulin
Coagulation Factor
Others
Global Blood Plasma Fractionation Technology Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Blood Plasma Fractionation Technology Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Others
Global Blood Plasma Fractionation Technology Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Blood Plasma Fractionation Technology Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Blood Plasma Fractionation Technology revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Blood Plasma Fractionation Technology revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Blood Plasma Fractionation Technology, market overview.
Chapter 2: Global Blood Plasma Fractionation Technology market size in revenue.
Chapter 3: Detailed analysis of Blood Plasma Fractionation Technology company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Blood Plasma Fractionation Technology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Blood Plasma Fractionation Technology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Blood Plasma Fractionation Technology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Blood Plasma Fractionation Technology Overall Market Size
2.1 Global Blood Plasma Fractionation Technology Market Size: 2022 VS 2029
2.2 Global Blood Plasma Fractionation Technology Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Blood Plasma Fractionation Technology Players in Global Market
3.2 Top Global Blood Plasma Fractionation Technology Companies Ranked by Revenue
3.3 Global Blood Plasma Fractionation Technology Revenue by Companies
3.4 Top 3 and Top 5 Blood Plasma Fractionation Technology Companies in Global Market, by Revenue in 2022
3.5 Global Companies Blood Plasma Fractionation Technology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Blood Plasma Fractionation Technology Players in Global Market
3.6.1 List of Global Tier 1 Blood Plasma Fractionation Technology Companies
3.6.2 List of Global Tier 2 and Tier 3 Blood Plasma Fractionation Technology Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Blood Plasma Fractionation Technology Market Size Markets, 2022 & 2029
4.1.2 Albumin
4.1.3 Immune Globulin
4.1.4 Coagulation Factor
4.1.5 Others
4.2 By Type – Global Blood Plasma Fractionation Technology Revenue & Forecasts
4.2.1 By Type – Global Blood Plasma Fractionation Technology Revenue, 2018-2023
4.2.2 By Type – Global Blood Plasma Fractionation Technology Revenue, 2024-2029
4.2.3 By Type – Global Blood Plasma Fractionation Technology Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Blood Plasma Fractionation Technology Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Others
5.2 By Application – Global Blood Plasma Fractionation Technology Revenue & Forecasts
5.2.1 By Application – Global Blood Plasma Fractionation Technology Revenue, 2018-2023
5.2.2 By Application – Global Blood Plasma Fractionation Technology Revenue, 2024-2029
5.2.3 By Application – Global Blood Plasma Fractionation Technology Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Blood Plasma Fractionation Technology Market Size, 2022 & 2029
6.2 By Region – Global Blood Plasma Fractionation Technology Revenue & Forecasts
6.2.1 By Region – Global Blood Plasma Fractionation Technology Revenue, 2018-2023
6.2.2 By Region – Global Blood Plasma Fractionation Technology Revenue, 2024-2029
6.2.3 By Region – Global Blood Plasma Fractionation Technology Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Blood Plasma Fractionation Technology Revenue, 2018-2029
6.3.2 US Blood Plasma Fractionation Technology Market Size, 2018-2029
6.3.3 Canada Blood Plasma Fractionation Technology Market Size, 2018-2029
6.3.4 Mexico Blood Plasma Fractionation Technology Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Blood Plasma Fractionation Technology Revenue, 2018-2029
6.4.2 Germany Blood Plasma Fractionation Technology Market Size, 2018-2029
6.4.3 France Blood Plasma Fractionation Technology Market Size, 2018-2029
6.4.4 U.K. Blood Plasma Fractionation Technology Market Size, 2018-2029
6.4.5 Italy Blood Plasma Fractionation Technology Market Size, 2018-2029
6.4.6 Russia Blood Plasma Fractionation Technology Market Size, 2018-2029
6.4.7 Nordic Countries Blood Plasma Fractionation Technology Market Size, 2018-2029
6.4.8 Benelux Blood Plasma Fractionation Technology Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Blood Plasma Fractionation Technology Revenue, 2018-2029
6.5.2 China Blood Plasma Fractionation Technology Market Size, 2018-2029
6.5.3 Japan Blood Plasma Fractionation Technology Market Size, 2018-2029
6.5.4 South Korea Blood Plasma Fractionation Technology Market Size, 2018-2029
6.5.5 Southeast Asia Blood Plasma Fractionation Technology Market Size, 2018-2029
6.5.6 India Blood Plasma Fractionation Technology Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Blood Plasma Fractionation Technology Revenue, 2018-2029
6.6.2 Brazil Blood Plasma Fractionation Technology Market Size, 2018-2029
6.6.3 Argentina Blood Plasma Fractionation Technology Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Blood Plasma Fractionation Technology Revenue, 2018-2029
6.7.2 Turkey Blood Plasma Fractionation Technology Market Size, 2018-2029
6.7.3 Israel Blood Plasma Fractionation Technology Market Size, 2018-2029
6.7.4 Saudi Arabia Blood Plasma Fractionation Technology Market Size, 2018-2029
6.7.5 UAE Blood Plasma Fractionation Technology Market Size, 2018-2029
7 Blood Plasma Fractionation Technology Companies Profiles
7.1 Takeda
7.1.1 Takeda Company Summary
7.1.2 Takeda Business Overview
7.1.3 Takeda Blood Plasma Fractionation Technology Major Product Offerings
7.1.4 Takeda Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.1.5 Takeda Key News & Latest Developments
7.2 CSL
7.2.1 CSL Company Summary
7.2.2 CSL Business Overview
7.2.3 CSL Blood Plasma Fractionation Technology Major Product Offerings
7.2.4 CSL Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.2.5 CSL Key News & Latest Developments
7.3 Grifols
7.3.1 Grifols Company Summary
7.3.2 Grifols Business Overview
7.3.3 Grifols Blood Plasma Fractionation Technology Major Product Offerings
7.3.4 Grifols Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.3.5 Grifols Key News & Latest Developments
7.4 Octapharma
7.4.1 Octapharma Company Summary
7.4.2 Octapharma Business Overview
7.4.3 Octapharma Blood Plasma Fractionation Technology Major Product Offerings
7.4.4 Octapharma Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.4.5 Octapharma Key News & Latest Developments
7.5 Kedrion
7.5.1 Kedrion Company Summary
7.5.2 Kedrion Business Overview
7.5.3 Kedrion Blood Plasma Fractionation Technology Major Product Offerings
7.5.4 Kedrion Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.5.5 Kedrion Key News & Latest Developments
7.6 LFB Group
7.6.1 LFB Group Company Summary
7.6.2 LFB Group Business Overview
7.6.3 LFB Group Blood Plasma Fractionation Technology Major Product Offerings
7.6.4 LFB Group Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.6.5 LFB Group Key News & Latest Developments
7.7 Biotest
7.7.1 Biotest Company Summary
7.7.2 Biotest Business Overview
7.7.3 Biotest Blood Plasma Fractionation Technology Major Product Offerings
7.7.4 Biotest Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.7.5 Biotest Key News & Latest Developments
7.8 BPL
7.8.1 BPL Company Summary
7.8.2 BPL Business Overview
7.8.3 BPL Blood Plasma Fractionation Technology Major Product Offerings
7.8.4 BPL Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.8.5 BPL Key News & Latest Developments
7.9 RAAS
7.9.1 RAAS Company Summary
7.9.2 RAAS Business Overview
7.9.3 RAAS Blood Plasma Fractionation Technology Major Product Offerings
7.9.4 RAAS Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.9.5 RAAS Key News & Latest Developments
7.10 CBPO
7.10.1 CBPO Company Summary
7.10.2 CBPO Business Overview
7.10.3 CBPO Blood Plasma Fractionation Technology Major Product Offerings
7.10.4 CBPO Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.10.5 CBPO Key News & Latest Developments
7.11 Hualan Bio
7.11.1 Hualan Bio Company Summary
7.11.2 Hualan Bio Business Overview
7.11.3 Hualan Bio Blood Plasma Fractionation Technology Major Product Offerings
7.11.4 Hualan Bio Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.11.5 Hualan Bio Key News & Latest Developments
7.12 Tiantan Bio
7.12.1 Tiantan Bio Company Summary
7.12.2 Tiantan Bio Business Overview
7.12.3 Tiantan Bio Blood Plasma Fractionation Technology Major Product Offerings
7.12.4 Tiantan Bio Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.12.5 Tiantan Bio Key News & Latest Developments
7.13 Shuanglin Bio
7.13.1 Shuanglin Bio Company Summary
7.13.2 Shuanglin Bio Business Overview
7.13.3 Shuanglin Bio Blood Plasma Fractionation Technology Major Product Offerings
7.13.4 Shuanglin Bio Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.13.5 Shuanglin Bio Key News & Latest Developments
7.14 Boya Bio
7.14.1 Boya Bio Company Summary
7.14.2 Boya Bio Business Overview
7.14.3 Boya Bio Blood Plasma Fractionation Technology Major Product Offerings
7.14.4 Boya Bio Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.14.5 Boya Bio Key News & Latest Developments
7.15 Yuanda Shuyang
7.15.1 Yuanda Shuyang Company Summary
7.15.2 Yuanda Shuyang Business Overview
7.15.3 Yuanda Shuyang Blood Plasma Fractionation Technology Major Product Offerings
7.15.4 Yuanda Shuyang Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.15.5 Yuanda Shuyang Key News & Latest Developments
7.16 Weiguang Bio
7.16.1 Weiguang Bio Company Summary
7.16.2 Weiguang Bio Business Overview
7.16.3 Weiguang Bio Blood Plasma Fractionation Technology Major Product Offerings
7.16.4 Weiguang Bio Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.16.5 Weiguang Bio Key News & Latest Developments
7.17 Nanyue Bio
7.17.1 Nanyue Bio Company Summary
7.17.2 Nanyue Bio Business Overview
7.17.3 Nanyue Bio Blood Plasma Fractionation Technology Major Product Offerings
7.17.4 Nanyue Bio Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.17.5 Nanyue Bio Key News & Latest Developments
7.18 KM Biologics
7.18.1 KM Biologics Company Summary
7.18.2 KM Biologics Business Overview
7.18.3 KM Biologics Blood Plasma Fractionation Technology Major Product Offerings
7.18.4 KM Biologics Blood Plasma Fractionation Technology Revenue in Global Market (2018-2023)
7.18.5 KM Biologics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 血漿分画技術の世界市場見通し2023年-2029年(Blood Plasma Fractionation Technology Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 遠心血球分離装置のグローバル市場展望 2023年-2029年：断続流型、連続流型
  • バイポーラプラズマ切除鏡のグローバル市場展望 2023年-2029年：長さ200mm以下、長さ200mm以上
  • 血中鉛検査サービスの世界市場見通し2023年-2029年
  • 血液腫瘍治療の世界市場見通し2023年-2029年
  • 血液浄化装置の世界市場見通し2023年-2029年